Developing Clinical Practice Guidelines

Reviewing, Reporting, and Publishing Guidelines ; Updating Guidelines ; and the Emerging Issues of Enhancing Guideline Implementability and Accounting for Comorbid Conditions in Guidelines Development

Published in: Implementation Science, v. 7, no. 62, July 2012, p. 1-7

Posted on RAND.org on July 01, 2012

by Paul G. Shekelle, Steven H. Woolf, Jeremy M. Grimshaw, Holger J. Schünemann, Martin P. Eccles

Read More

Access further information on this document at Implementation Science

This article was published outside of RAND. The full text of the article can be found at the link above.

Clinical practice guidelines are one of the foundations of efforts to improve health care. In 1999, we authored a paper about methods to develop guidelines. Since it was published, the methods of guideline development have progressed both in terms of methods and necessary procedures and the context for guideline development has changed with the emergence of guideline clearing houses and large scale guideline production organisations (such as the UK National Institute for Health and Clinical Excellence). It therefore seems timely to, in a series of three articles, update and extend our earlier paper. In this third paper we discuss the issues of: reviewing, reporting, and publishing guidelines; updating guidelines; and the two emerging issues of enhancing guideline implementability and how guideline developers should approach dealing with the issue of patients who will be the subject of guidelines having co-morbid conditions.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.